{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T05:05:51Z","timestamp":1735880751005,"version":"3.32.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":206,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.clinsp.2024.100473","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T07:25:17Z","timestamp":1724829917000},"page":"100473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["COVID-19 and myocardial injury: Targeting elevated biomarkers for potential novel therapies"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2272-9102","authenticated-orcid":false,"given":"Pengyang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5683-7844","authenticated-orcid":false,"given":"Qun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4187-2919","authenticated-orcid":false,"given":"Ion S.","family":"Jovin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anit","family":"Mankad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5073-9765","authenticated-orcid":false,"given":"Jose F.","family":"Huizar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7644-9720","authenticated-orcid":false,"given":"John D.","family":"Markley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0949-4567","authenticated-orcid":false,"given":"Bradley","family":"Bart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4061-9129","authenticated-orcid":false,"given":"Brack","family":"Hattler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9672-7065","authenticated-orcid":false,"given":"Edward","family":"Lesnefsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3933-6666","authenticated-orcid":false,"given":"Edward O.","family":"McFalls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.clinsp.2024.100473_bib0001","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/cvr\/cvx183","article-title":"Cardiac troponins: from myocardial infarction to chronic disease","volume":"113","author":"Park","year":"2017","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.clinsp.2024.100473_bib0002","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/ehjacc\/zuaa037","article-title":"2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group","volume":"10","author":"Schiele","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"3","key":"10.1016\/j.clinsp.2024.100473_bib0003","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"issue":"7-8","key":"10.1016\/j.clinsp.2024.100473_bib0004","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/10408363.2017.1410777","article-title":"Cardiac troponins: 25 years on the stage and still improving their clinical value","volume":"54","author":"Alqu\u00e9zar-Arb\u00e9","year":"2017","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"2","key":"10.1016\/j.clinsp.2024.100473_bib0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/eurheartj\/ehn517","article-title":"Interpreting troponin elevations: do we need multiple diagnoses?","volume":"30","author":"Pierpont","year":"2009","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.clinsp.2024.100473_bib0006","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.amjmed.2021.10.038","article-title":"The troponin complex: discriminating the signal from the noise","volume":"135","author":"Jovin","year":"2022","journal-title":"Am J Med"},{"issue":"18","key":"10.1016\/j.clinsp.2024.100473_bib0007","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.clinsp.2024.100473_bib0008","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jamacardio.2019.0716","article-title":"Misclassification of myocardial injury as myocardial infarction: implications for assessing outcomes in value-based programs","volume":"4","author":"McCarthy","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"7","key":"10.1016\/j.clinsp.2024.100473_bib0009","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00392-018-1403-3","article-title":"Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis","volume":"108","author":"Vargas","year":"2019","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"10.1016\/j.clinsp.2024.100473_bib0010","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.carrev.2019.04.009","article-title":"Implications of misclassification of type 2 myocardial infarction on clinical outcomes","volume":"21","author":"Hawatmeh","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100473_bib0011","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.119.043100","article-title":"Incidence, trends, and outcomes of type 2 myocardial infarction in a community cohort","volume":"141","author":"Raphael","year":"2020","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.clinsp.2024.100473_bib0012","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jacc.2020.12.034","article-title":"Patient characteristics and clinical outcomes of type 1 versus type 2 myocardial infarction","volume":"77","author":"McCarthy","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100473_bib0013","first-page":"41","article-title":"Type-II myocardial infarction and chronic myocardial injury rates, invasive management, and 4-year mortality among consecutive patients undergoing high-sensitivity troponin T testing in the emergency department","volume":"6","author":"Etaher","year":"2020","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100473_bib0014","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.3390\/jcm9061686","article-title":"Long-term prognosis of patients with myocardial infarction type 1 and type 2 with and without involvement of coronary vasospasm","volume":"9","author":"Sato","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.clinsp.2024.100473_bib0015","first-page":"497","volume":"395","author":"Huang","year":"2020"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100473_bib0016","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3390\/diagnostics12061373","article-title":"Inflammatory and cardiac biomarkers in relation with post-acute COVID-19 and mortality: what we know after successive pandemic waves","volume":"12","author":"Lionte","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100473_bib0017","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3390\/cells11060922","article-title":"Biomarkers associated with cardiovascular disease in COVID-19","volume":"11","author":"Kaufmann","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.clinsp.2024.100473_bib0018","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.amjcard.2020.11.009","article-title":"Meta-analysis comparing outcomes in patients with and without cardiac injury and coronavirus disease 2019 (COVID 19)","volume":"141","author":"Bansal","year":"2021","journal-title":"Am J Cardiol"},{"issue":"23","key":"10.1016\/j.clinsp.2024.100473_bib0019","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1093\/eurheartj\/ehaa1103","article-title":"C-reactive protein and clinical outcomes in patients with COVID-19","volume":"42","author":"Smilowitz","year":"2021","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.clinsp.2024.100473_bib0020","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.jacc.2020.08.069","article-title":"Characterization of myocardial injury in patients with COVID-19","volume":"76","author":"Giustino","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.clinsp.2024.100473_bib0021","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/ehjacc\/zuac075","article-title":"Major adverse cardiovascular events after diagnosis of myocardial injury and types 1 and 2 myocardial infarction","volume":"11","author":"Knott","year":"2022","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"7","key":"10.1016\/j.clinsp.2024.100473_bib0022","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.amjmed.2011.02.024","article-title":"Outcomes of hospitalized patients with non-acute coronary syndrome and elevated cardiac troponin level","volume":"124","author":"McFalls","year":"2011","journal-title":"Am J Med"},{"issue":"14","key":"10.1016\/j.clinsp.2024.100473_bib0023","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.jacc.2019.02.018","article-title":"Type 2 myocardial infarction: JACC review topic of the week","volume":"73","author":"Sandoval","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.clinsp.2024.100473_bib0024","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s12603-020-1499-9","article-title":"Older adults hospitalized with covid-19: clinical characteristics and early outcomes from a single center in istanbul, Turkey","volume":"24","author":"Medetalibeyoglu","year":"2020","journal-title":"J Nutr Health Aging"},{"issue":"7","key":"10.1016\/j.clinsp.2024.100473_bib0025","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.clinsp.2024.100473_bib0026","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.clinsp.2024.100473_bib0027","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jacbts.2022.08.005","article-title":"Myocardial injury and altered gene expression associated with SARS-CoV-2 infection or mRNA Vaccination","volume":"8","author":"Altman","year":"2023","journal-title":"JACC Basic Transl Sci"},{"issue":"3","key":"10.1016\/j.clinsp.2024.100473_bib0028","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00395-020-0791-5","article-title":"COVID-19 in the heart and the lungs: could we \"Notch\" the inflammatory storm?","volume":"115","author":"Rizzo","year":"2020","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100473_bib0029","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12933-019-0974-2","article-title":"High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus","volume":"18","author":"Wong","year":"2019","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100473_bib0030","article-title":"Can B-type natriuretic peptide (BNP) levels serve as an early predictor of clinical severity in patients with COVID-19 pneumonia?","volume":"68","author":"Cilingir","year":"2022","journal-title":"Clin Lab"},{"issue":"2","key":"10.1016\/j.clinsp.2024.100473_bib0031","doi-asserted-by":"crossref","first-page":"141","DOI":"10.34172\/jcvtr.2021.26","article-title":"Prognostic significance of N-Terminal Pro-BNP in patients with COVID-19 pneumonia without previous history of heart failure","volume":"13","author":"Sel\u00e7uk","year":"2021","journal-title":"J Cardiovasc Thorac Res"},{"key":"10.1016\/j.clinsp.2024.100473_bib0032","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.12659\/MSM.912318","article-title":"Correlations of changes in brain natriuretic peptide (BNP) and cardiac troponin I (cTnI) with levels of c-reactive protein (CRP) and TNF-alpha in pediatric patients with sepsis","volume":"25","author":"Zhang","year":"2019","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.clinsp.2024.100473_bib0033","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.avsg.2019.09.017","article-title":"NT-Pro BNP predicts myocardial injury post-vascular surgery and is reduced with CoQ10: a randomized double-blind trial","volume":"64","author":"Khan","year":"2020","journal-title":"Ann Vasc Surg"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100473_bib0034","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00380-016-0923-x","article-title":"Low circulating coenzyme Q10 during acute phase is associated with inflammation, malnutrition, and in-hospital mortality in patients admitted to the coronary care unit","volume":"32","author":"Shimizu","year":"2017","journal-title":"Heart Vessels"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100473_bib0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/irv.12608","article-title":"Coenzyme Q10 in acute influenza","volume":"13","author":"Chase","year":"2019","journal-title":"Influenza and other Respiratory Viruses"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100473_bib0036","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jchf.2014.06.008","article-title":"The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure results from Q-SYMBIO: a randomized double-blind trial","volume":"2","author":"Mortensen","year":"2014","journal-title":"JACC Heart Failure"},{"issue":"2","key":"10.1016\/j.clinsp.2024.100473_bib0037","first-page":"147","article-title":"Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial","volume":"26","author":"Mortensen","year":"2019","journal-title":"Cardiol J"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100473_bib0038","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12872-017-0628-9","article-title":"Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials","volume":"17","author":"Lei","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"issue":"37","key":"10.1016\/j.clinsp.2024.100473_bib0039","doi-asserted-by":"crossref","first-page":"e12372","DOI":"10.1097\/MD.0000000000012372","article-title":"Novel biochemical predictors of unfavorable prognosis for stable coronary disease","volume":"97","author":"Cacko","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100473_bib0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1253\/circj.CJ-16-0790","article-title":"Preprocedural high-sensitivity C-reactive protein predicts long-term outcome of percutaneous coronary intervention","volume":"81","author":"Wada","year":"2016","journal-title":"Circ J"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100473_bib0041","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","article-title":"Targeting cardiovascular inflammation: next steps in clinical translation","volume":"42","author":"Lawler","year":"2021","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.clinsp.2024.100473_bib0042","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100473_bib0043","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100473_bib0044","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.clnu.2016.03.025","article-title":"Scores of nutritional risk and parameters of nutritional status assessment as predictors of in-hospital mortality and readmissions in the general hospital population","volume":"35","author":"Budzynski","year":"2016","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.clinsp.2024.100473_bib0045","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jtcvs.2009.03.050","article-title":"Preoperative C-reactive protein levels to predict early and late mortalities after coronary artery bypass surgery: eight years of follow-up","volume":"138","author":"van Straten","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100473_bib0046","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.ejcts.2006.02.022","article-title":"Preoperative C-reactive protein is predictive of long-term outcome after coronary artery bypass surgery","volume":"29","author":"Kangasniemi","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"10.1016\/j.clinsp.2024.100473_bib0047","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3390\/antibiotics8040176","article-title":"The preoperative inflammatory status affects the clinical outcome in cardiac surgery","volume":"8","author":"D'Agostino","year":"2019","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.clinsp.2024.100473_bib0048","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jvs.2006.08.048","article-title":"Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery","volume":"45","author":"Owens","year":"2007","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1016\/j.clinsp.2024.100473_bib0049","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejvs.2017.05.009","article-title":"Systematic review and meta-analysis of the association between c-reactive protein and major cardiovascular events in patients with peripheral artery disease","volume":"54","author":"Singh","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"4","key":"10.1016\/j.clinsp.2024.100473_bib0050","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1365-2044.2008.05786.x","article-title":"A meta-analysis of the utility of C-reactive protein in predicting early, intermediate-term and long term mortality and major adverse cardiac events in vascular surgical patients","volume":"64","author":"Padayachee","year":"2009","journal-title":"Anaesthesia"},{"issue":"6","key":"10.1016\/j.clinsp.2024.100473_bib0051","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.avsg.2014.01.012","article-title":"Combined use of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for risk stratification of vascular surgery patients","volume":"28","author":"Scrutinio","year":"2014","journal-title":"Ann Vasc Surg"},{"issue":"7","key":"10.1016\/j.clinsp.2024.100473_bib0052","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132995","article-title":"Predictive value of C-reactive protein for major complications after major abdominal surgery: a systematic review and pooled-analysis","volume":"10","author":"Straatman","year":"2015","journal-title":"PLoS One"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593224001509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593224001509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T04:41:39Z","timestamp":1735792899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593224001509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":52,"alternative-id":["S1807593224001509"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2024.100473","relation":{},"ISSN":["1807-5932"],"issn-type":[{"type":"print","value":"1807-5932"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 and myocardial injury: Targeting elevated biomarkers for potential novel therapies","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2024.100473","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100473"}}